Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Identification of Novel Lncrnas That Predict Survival in AML Patients and Modulate Leukemic Cells

Sarah Grasedieck, MSc, Christoph Rueß, MSc, Nicole Pochert, MSc, Susanne Lux, MSc, Adrian Schwarzer, MD PhD, Jan-Henning Klusmann, Mojca Jongen-Lavrencic, MD PhD, Jonathan R. Pollack, MD PhD, Arefeh Rouhi, PhD, Florian Kuchenbauer, MD PhD

Blood (2018) 132 (Supplement 1): 3909.

https://doi.org/10.1182/blood-2018-99-118331

Published: 2018

Journal Articles

Combined Analysis of Valproic Acid Induced MicroRNA and Gene Expression Changes in Acute Myeloid Leukemia.

Annika C. Russ, Martin Dugas, MD, Sonja C. Schmid-Fetzer, Richard F. Schlenk, MD, Jonathan R. Pollack, MD, PhD, Konstanze Dohner, MD, Mathias Schmid, MD, Hartmut Dohner, MD, Lars Bullinger, MD

Blood (2007) 110 (11): 869.

https://doi.org/10.1182/blood.V110.11.869.869

Published: 2007

Journal Articles

In Vitro and In Vivo Monitoring of Valproic Acid Effects on Gene Expression Signatures in Adult Acute Myeloid Leukemia.

Lars Bullinger, MD, Konstanze Dohner, MD, Richard F. Schlenk, MD, Frank G. Rucker, MD, Jonathan R. Pollack, MD, PhD, Hartmut Dohner, MD, Mathias Schmid, MD

Blood (2006) 108 (11): 2605.

https://doi.org/10.1182/blood.V108.11.2605.2605

Published: 2006

Journal Articles

Characterization of NPM1 -Mutated/ FLT3 ITD-Negative Acute Myeloid Leukemia with Normal Karyotype by Gene Expression Profiling.

Lars Bullinger, MD, Konstanze Dohner, MD, Raphael Kranz, Frank G. Rucker, MD, Stefan Frohling, MD, Richard F. Schlenk, MD, Jonathan R. Pollack, MD, PhD, Hartmut Dohner, MD

Blood (2006) 108 (11): 155.

https://doi.org/10.1182/blood.V108.11.155.155

Published: 2006

Journal Articles

A FLT3 Gene-Expression Signature Outperforms FLT3 Status in Predicting Clinical Outcome for Patients with Normal Karyotype AML.

Lars Bullinger, MD, Konstanze Dohner, MD, Christoph Stirner, Frank G. Rucker, MD, Stefan Frohling, MD, Young H. Kim, Richard F. Schlenk, MD, Robert Tibshirani, PhD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD

Blood (2006) 108 (11): 2311.

https://doi.org/10.1182/blood.V108.11.2311.2311

Published: 2006

Journal Articles

Gene Expression Profiling Identifies Distinct Subclasses in Core Binding Factor Acute Myeloid Leukemia.

Lars Bullinger, MD, Stephan Kurz, Konstanze Dohner, MD, Claudia Scholl, MD, Stefan Frohling, MD, Richard F. Schlenk, MD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD

Blood (2005) 106 (11): 673.

https://doi.org/10.1182/blood.V106.11.673.673

Published: 2005

Journal Articles

Prognostic Gene-Expression Signatures in Adult Acute Myeloid Leukemia with Normal Karyotype.

Lars Bullinger, MD, Eric Bair, PhD, Raphael Kranz, Konstanze Dohner, MD, Stefan Frohling, MD, Richard F. Schlenk, MD, Robert Tibshirani, PhD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD

Blood (2005) 106 (11): 756.

https://doi.org/10.1182/blood.V106.11.756.756

Published: 2005

Journal Articles

Array-CGH and Gene Expression Profiling Based Molecular Characterization of Myeloid Leukemia Cell Lines.

Frank G. Rucker, MD, Sandrine Sander, Konstanze Dohner, MD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD, Lars Bullinger, MD

Blood (2005) 106 (11): 4397.

https://doi.org/10.1182/blood.V106.11.4397.4397

Published: 2005

Journal Articles

Identification of Distinct inv(16) Subclasses in Adult Acute Myeloid Leukemia Based on Gene Expression Profiling.

Lars Bullinger, MD, Claudia Scholl, MD, Eric Bair, Konstanze Dohner, MD, Stefan Frohling, MD, Richard F. Schlenk, MD, Robert Tibshirani, PhD, Hartmut Dohner, MD, Jonathan R. Pollack, MD, PhD

Blood (2004) 104 (11): 2037.

https://doi.org/10.1182/blood.V104.11.2037.2037

Published: 2004

NARROW

Identification of Novel Lncrnas That Predict Survival in AML Patients and Modulate Leukemic Cells

Combined Analysis of Valproic Acid Induced MicroRNA and Gene Expression Changes in Acute Myeloid Leukemia.

In Vitro and In Vivo Monitoring of Valproic Acid Effects on Gene Expression Signatures in Adult Acute Myeloid Leukemia.

Characterization of NPM1 -Mutated/ FLT3 ITD-Negative Acute Myeloid Leukemia with Normal Karyotype by Gene Expression Profiling.

A FLT3 Gene-Expression Signature Outperforms FLT3 Status in Predicting Clinical Outcome for Patients with Normal Karyotype AML.

Gene Expression Profiling Identifies Distinct Subclasses in Core Binding Factor Acute Myeloid Leukemia.

Prognostic Gene-Expression Signatures in Adult Acute Myeloid Leukemia with Normal Karyotype.

Array-CGH and Gene Expression Profiling Based Molecular Characterization of Myeloid Leukemia Cell Lines.

Identification of Distinct inv(16) Subclasses in Adult Acute Myeloid Leukemia Based on Gene Expression Profiling.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only